Pain-Related PANoptosis Gene Signature Predicts Prognosis and Guides Therapy in Oral Squamous Cell Carcinoma
Technology in Cancer Research & Treatment · 2026-07 · 25
DOI: 10.1177/15330338261468835 ↗Kurz gefasst
Fachartikel in der Zeitschrift Technology in Cancer Research & Treatment, online erschienen am 20.07.2026. Verfasst von Ying Yao und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Stomatological Hospital of Chongqing Medical University, Chongqing, China. Hauptthemen laut MEDLINE: Mouth Neoplasms, Biomarkers, Tumor, Pain, Carcinoma, Squamous Cell. Die Arbeit nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
This study aimed to develop a prognostic model based on pain-related PANoptosis genes to enhance therapeutic decision-making for oral squamous cell carcinoma (OSCC) patients.
Methods
RNA sequencing data from 323 OSCC patients and 43 controls in the TCGA cohort were analyzed to identify differentially expressed genes (DEGs). Correlation analysis revealed pain-related PANoptosis genes, and a prognostic model was developed using Cox and LASSO regression and validated in the GSE42743 cohort. Immune microenvironment differences were assessed, and drug sensitivity was predicted. qRT-PCR was employed to validate gene expression alterations in OSCC tissues.
Results
Among 2,253 DEGs, 38 overlapped with PANoptosis-related genes, leading to the identification of 37 pain-related PANoptosis genes that characterized two OSCC subtypes. A Pain-Related PANoptosis-gene model (including CA9, DEFB1, DES, IGLL5, LCE3D, LYNX1, SPINK7) achieved AUCs of 0.626 and 0.690 in the TCGA and validation cohorts, respectively. Significant immune microenvironment differences were noted, with high-risk patients showing immune characteristics associated with a more immunosuppressive environment. GSEA identified activated pathways like autophagy and chemokine signaling in high-risk patients.
Conclusions
The pain-related PANoptosis-gene model effectively stratifies OSCC patients by risk. Sepantronium bromide may represent a potential therapeutic candidate for high-risk patients; however, further experimental validation is required.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, Stomatological Hospital of Chongqing Medical University, Chongqing, China.
- Chongqing Key Laboratory of Oral Diseases and Biomedical Sciences; Chongqing Municipal Key Laboratory of Oral Biomedical Engineering of Higher Education, Stomatological Hospital of Chongqing Medical University, Chongqin…
- Department of Anesthesiology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
- Department of Oral and Maxillofacial Surgery, Stomatological Hospital of Chongqing Medical University, Chongqing, China.
Zitieren
APA
Yao, Y., Liu, Q., Chen, S., Wang, Y., & Gao, X. (2026). Pain-Related PANoptosis Gene Signature Predicts Prognosis and Guides Therapy in Oral Squamous Cell Carcinoma. Technology in Cancer Research & Treatment, 25. https://doi.org/10.1177/15330338261468835
Vancouver
Yao Y, Liu Q, Chen S, Wang Y, Gao X. Pain-Related PANoptosis Gene Signature Predicts Prognosis and Guides Therapy in Oral Squamous Cell Carcinoma. Technology in Cancer Research & Treatment. 2026;25. doi:10.1177/15330338261468835
BibTeX
@article{Yao2026,
author = {Yao, Ying and Liu, Qi and Chen, Silu and Wang, Yan and Gao, Xiang},
title = {Pain-Related PANoptosis Gene Signature Predicts Prognosis and Guides Therapy in Oral Squamous Cell Carcinoma},
journal = {Technology in Cancer Research & Treatment},
year = {2026},
volume = {25},
doi = {10.1177/15330338261468835}
}
EUVIMED